MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Gut dysbiosis in Parkinson’s disease with motor complications

    K. Takahashi, H. Nishiwaki, M. Ito, K. Iwaoka, K. Yamahara, K. Takahashi, Y. Suzuki, K. Taguchi, Y. Tsuboi, K. Kashihara, M. Hirayama, K. Ohno, T. Maeda (Shiwa, Japan)

    Objective: We aimed to identify gut dysbiosis in Parkinson's disease patients with motor complications. Background: Recently, several evidences suggest that the gut microbiota is associated…
  • MDS Virtual Congress 2021

    Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

    M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)

    Objective: To identify protein biomarkers in plasma of patients with Parkinson’s disease (PD). Background: Inflammation plays a key role in the initiation and progression of…
  • MDS Virtual Congress 2021

    Lipid metabolism alterations in the lysosomal membrane promotes chaperone-mediated autophagy dysfunction and alpha-synuclein pathology in Parkinson’s disease associated to GBA

    A. Navarro-Romero, I. Fernandez-Gonzalez, M. Montpeyo, J. Riera, E. Pradas, JA. Arranz, C. Carnicer-Caceres, M. Martinez-Vicente (Barcelona, Spain)

    Objective: The objective of this study was to generate and characterize a new in vitro neuronal model of Parkinson's diseases associated to GBA (PD-GBA) that…
  • MDS Virtual Congress 2021

    Substantia nigra pars compacta integrity is associated with DRT-related motor symptom improvement in Parkinson’s disease

    S. Atkinson, R. Seo, D. Peterson, B. Cholerton, SC. Hu, T. Montine, T. Grabowski, C. Zabetian, S. Rane (Seattle, USA)

    Objective: To study the correlation between substantia nigra white matter integrity and response of motor symptoms to dopamine replacement therapy (DRT) in Parkinson’s disease (PD).…
  • MDS Virtual Congress 2021

    Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

    A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: We aimed to study the association between presynaptic striatal dopamine uptake and functional connectivity (FC) patterns among healthy first-degree relatives of PD patients with…
  • MDS Virtual Congress 2021

    Patterns of Cortical Thinning in Patients with Parkinson’s Disease

    H. Jergas, JC. Baldermann, JN. Petry-Schmelzer, H. Dafsari, V. Visser-Vanderwalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate patterns of cortical thickness that are associated with disease severity and response to levodopa. Background: Cortex affection is a neuropathological correlate of…
  • MDS Virtual Congress 2021

    Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

    T. Payne, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine if 31P-MRS can identify mitochondrial dysfunction in-vivo and if this correlates with in-vitro measures of mitochondrial function obtained from patient derived fibroblasts…
  • MDS Virtual Congress 2021

    Dysfunctional resting connectivity in early stage of Parkinson’s disease is indistinguishable from connectivity in REM sleep behaviour disorder

    P. štofaniková, F. Růžička, K. Mueller, T. Ballarini, E. Růžička, K. šonka, P. Dušek, R. Jech (Prague, Czech Republic)

    Objective: To investigate the differences in functional connectivity among healthy subjects (HC), patients with REM sleep behaviour disorder (RBD) and levodopa-naïve patients in early stage…
  • MDS Virtual Congress 2021

    Distinct cholinergic reactivity to dopamine is related with differed parkinsonian tremor responsiveness

    J. Wu, C. Zhou, T. Guo, X. Guan, X. Bai, H. Wu, J. Chen, J. Wen, X. Liu, P. Huang, X. Xu, M. Zhang (Hangzhou, China)

    Objective: We aimed at exploring the mechanisms of differed tremor responsiveness to dopamine through investigating the cholinergic and dopaminergic reactivity during dopamine administration in PD.…
  • MDS Virtual Congress 2021

    Impact of the postural function сhanges on quality of life and daily activity in patients with Parkinson’s disease during DBS

    A. Buniak, S. Likhachev (Minsk, Belarus)

    Objective: Quality of life (QOL) and activity of daily living (ADL) in PD patients depends on the severity of motor disorders, including changes of postural…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley